190 related articles for article (PubMed ID: 24777899)
21. Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine.
Permala J; Tarning J; Nosten F; White NJ; Karlsson MO; Bergstrand M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242661
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.
Salman S; Page-Sharp M; Batty KT; Kose K; Griffin S; Siba PM; Ilett KF; Mueller I; Davis TM
Antimicrob Agents Chemother; 2012 Jun; 56(6):3288-97. PubMed ID: 22470119
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
Benjamin JM; Moore BR; Salman S; Page-Sharp M; Tawat S; Yadi G; Lorry L; Siba PM; Batty KT; Robinson LJ; Mueller I; Davis TM
Antimicrob Agents Chemother; 2015 Jul; 59(7):4260-71. PubMed ID: 25963981
[TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.
Manning J; Vanachayangkul P; Lon C; Spring M; So M; Sea D; Se Y; Somethy S; Phann ST; Chann S; Sriwichai S; Buathong N; Kuntawunginn W; Mitprasat M; Siripokasupkul R; Teja-Isavadharm P; Soh E; Timmermans A; Lanteri C; Kaewkungwal J; Auayporn M; Tang D; Chour CM; Prom S; Haigney M; Cantilena L; Saunders D
Antimicrob Agents Chemother; 2014 Oct; 58(10):6056-67. PubMed ID: 25092702
[TBL] [Abstract][Full Text] [Related]
26. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
[TBL] [Abstract][Full Text] [Related]
27. Progress in the development of piperaquine combinations for the treatment of malaria.
D'alessandro U
Curr Opin Infect Dis; 2009 Dec; 22(6):588-92. PubMed ID: 19773652
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamics of doxycycline in a murine malaria model.
Batty KT; Law AS; Stirling V; Moore BR
Antimicrob Agents Chemother; 2007 Dec; 51(12):4477-9. PubMed ID: 17876000
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Guo J; Guiguemde AW; Bentura-Marciano A; Clark J; Haynes RK; Chan WC; Wong HN; Hunt NH; Guy RK; Golenser J
Antimicrob Agents Chemother; 2012 Jan; 56(1):163-73. PubMed ID: 22006004
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of dihydroartemisinin/piperaquine in patients with non-complicated Plasmodium falciparum malaria in Yaoundé, Cameroon.
Mairet-Khedim M; Nsango S; Ngou C; Menard S; Roesch C; Khim N; Srun S; Iriart X; Lanot T; Otam L; Abega F; Ayong L; Morlais I; Gandia P; Witkowski B; Berry A
J Antimicrob Chemother; 2021 Oct; 76(11):3037-3044. PubMed ID: 34453535
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of compound dihydroartemisinin/piperaquine in treatment of uncomplicated falciparum malaria in Myanmar].
Liu H; Yang HL; Zhang J; Li CF; Nie RH; Wang HY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Aug; 29(4):296-8. PubMed ID: 21972607
[TBL] [Abstract][Full Text] [Related]
32. Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model.
Janse CJ; Waters AP; Kos J; Lugt CB
Int J Parasitol; 1994 Jul; 24(4):589-94. PubMed ID: 8082988
[TBL] [Abstract][Full Text] [Related]
33. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
Hoglund RM; Adam I; Hanpithakpong W; Ashton M; Lindegardh N; Day NP; White NJ; Nosten F; Tarning J
Malar J; 2012 Nov; 11():398. PubMed ID: 23190801
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Snyder C; Chollet J; Santo-Tomas J; Scheurer C; Wittlin S
Exp Parasitol; 2007 Mar; 115(3):296-300. PubMed ID: 17087929
[TBL] [Abstract][Full Text] [Related]
35. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.
Price RN; Hasugian AR; Ratcliff A; Siswantoro H; Purba HL; Kenangalem E; Lindegardh N; Penttinen P; Laihad F; Ebsworth EP; Anstey NM; Tjitra E
Antimicrob Agents Chemother; 2007 Nov; 51(11):4090-7. PubMed ID: 17846129
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy of sulphadoxine-pyrimethamine and dihydroartemisinin-piperaquine against malaria infection during late-stage pregnancy in mice.
Akinola O; Ategbero E; Amusan AI; Gbotosho GO
Exp Parasitol; 2023 May; 248():108500. PubMed ID: 36893971
[TBL] [Abstract][Full Text] [Related]
37. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
Tarning J; Rijken MJ; McGready R; Phyo AP; Hanpithakpong W; Day NP; White NJ; Nosten F; Lindegardh N
Antimicrob Agents Chemother; 2012 Apr; 56(4):1997-2007. PubMed ID: 22252822
[TBL] [Abstract][Full Text] [Related]
39. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
[TBL] [Abstract][Full Text] [Related]
40. Enantiomerically pure amino-alcohol quinolines: in vitro anti-malarial activity in combination with dihydroartemisinin, cytotoxicity and in vivo efficacy in a Plasmodium berghei mouse model.
Mullié C; Taudon N; Degrouas C; Jonet A; Pascual A; Agnamey P; Sonnet P
Malar J; 2014 Oct; 13():407. PubMed ID: 25319003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
